Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMRT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,054
Award facts
- Contract value 100% obligated
- $20,053.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,053.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on February 3, 2026, with an ultimate completion date of February 4, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. will perform work at its Park Ridge, Illinois location and will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $500 million ceiling and extends through December 2036. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical inventories—including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals—to military healthcare facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated substantial performance across diverse product categories and therapeutic classes essential to Department of Defense medical operations.
Quick answers
Who was awarded contract SPE2DU26FEMRT?
SPE2DU26FEMRT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DU26FEMRT worth?
The government has obligated $20,054 on SPE2DU26FEMRT.
Is contract SPE2DU26FEMRT an order under another contract?
Yes. SPE2DU26FEMRT is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMRT competed?
The extent of competition for SPE2DU26FEMRT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award